Literature DB >> 9862772

Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block.

G A Mealing1, T H Lanthorn, C L Murray, D L Small, P Morley.   

Abstract

This study characterizes the trapping of block of N-methyl-D-aspartic acid (NMDA)-induced currents by three structurally distinct, use-dependent NMDA receptor antagonists with similar rapid on-off rates. The antagonism of whole-cell currents in cultured rat cortical neurons by AR-R15896AR, ketamine, and memantine was examined. All three compounds produced a steady-state block after a 30-s coapplication, which was fully relieved after 50 s of NMDA exposure. The amplitudes of block caused by 50 microM AR-R15896AR, 10 microM ketamine, or 10 microM memantine were not significantly different, being 82 +/- 1%, 80 +/- 2%, and 81 +/- 2%, respectively. All three NMDA receptor antagonists exhibited trapping of block that was not significantly increased by extending the agonist/antagonist coapplication beyond 30 s. Although the initial blocks were similar, after 120 s of washout without agonist present, there were significant differences in trapping of block between antagonists, as only 54 +/- 3% of the AR-R15896AR block, 86 +/- 1% of the ketamine block, and 71 +/- 4% of the memantine block remained trapped. The lack of complete trapping is consistent with closed-channel egress by these compounds. Higher antagonist concentrations produced larger initial blocks, but the degree of trapping block was not significantly different from that at lower antagonist concentrations. The results demonstrate that differences in the degree of trapping exist among use-dependent NMDA receptor antagonists even when on and off rates are similar. These differences are correlated with measures of therapeutic index.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9862772

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 3.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework.

Authors:  David Cook; Dearg Brown; Robert Alexander; Ruth March; Paul Morgan; Gemma Satterthwaite; Menelas N Pangalos
Journal:  Nat Rev Drug Discov       Date:  2014-05-16       Impact factor: 84.694

Review 4.  New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.

Authors:  Elias Dakwar; Edward V Nunes
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

5.  Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains.

Authors:  Michael R Weed; Mark Bookbinder; Joseph Polino; Deborah Keavy; Rudolf N Cardinal; Jean Simmermacher-Mayer; Fu-ni L Cometa; Dalton King; Srinivasan Thangathirupathy; John E Macor; Linda J Bristow
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

6.  Noncompetitive, voltage-dependent NMDA receptor antagonism by hydrophobic anions.

Authors:  Andrew J Linsenbardt; Mariangela Chisari; Andrew Yu; Hong-Jin Shu; Charles F Zorumski; Steven Mennerick
Journal:  Mol Pharmacol       Date:  2012-11-09       Impact factor: 4.436

7.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

8.  GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput.

Authors:  Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Bipolar Disord       Date:  2016-11-29       Impact factor: 6.744

9.  A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.

Authors:  Carlos A Zarate; Daniel Mathews; Lobna Ibrahim; Jose Franco Chaves; Craig Marquardt; Immaculata Ukoh; Libby Jolkovsky; Nancy E Brutsche; Mark A Smith; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.